10322 related articles for article (PubMed ID: 15799825)
1. Antisense-mediated suppression of Heparanase gene inhibits melanoma cell invasion.
Roy M; Reiland J; Murry BP; Chouljenko V; Kousoulas KG; Marchetti D
Neoplasia; 2005 Mar; 7(3):253-62. PubMed ID: 15799825
[TBL] [Abstract][Full Text] [Related]
2. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
Aucoin R; Reiland J; Roy M; Marchetti D
J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
[TBL] [Abstract][Full Text] [Related]
3. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
4. Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells.
Uno F; Fujiwara T; Takata Y; Ohtani S; Katsuda K; Takaoka M; Ohkawa T; Naomoto Y; Nakajima M; Tanaka N
Cancer Res; 2001 Nov; 61(21):7855-60. PubMed ID: 11691803
[TBL] [Abstract][Full Text] [Related]
5. Selective heparanase localization in malignant melanoma.
Murry BP; Greiter-Wilke A; Paulsen DP; Hiatt KM; Beltrami CA; Marchetti D
Int J Oncol; 2005 Feb; 26(2):345-52. PubMed ID: 15645118
[TBL] [Abstract][Full Text] [Related]
6. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
7. HPSE-1 expression and functionality in differentiating neural cells.
Moretti M; Sinnappah-Kang ND; Toller M; Curcio F; Marchetti D
J Neurosci Res; 2006 Mar; 83(4):694-701. PubMed ID: 16429446
[TBL] [Abstract][Full Text] [Related]
8. Early growth response gene 1 (EGR1) regulates heparanase gene transcription in tumor cells.
de Mestre AM; Rao S; Hornby JR; Soe-Htwe T; Khachigian LM; Hulett MD
J Biol Chem; 2005 Oct; 280(42):35136-47. PubMed ID: 16093249
[TBL] [Abstract][Full Text] [Related]
9. Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model.
Murry BP; Blust BE; Singh A; Foster TP; Marchetti D
J Cell Biochem; 2006 Feb; 97(2):217-25. PubMed ID: 16288472
[TBL] [Abstract][Full Text] [Related]
10. FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells.
Reiland J; Kempf D; Roy M; Denkins Y; Marchetti D
Neoplasia; 2006 Jul; 8(7):596-606. PubMed ID: 16867222
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
[TBL] [Abstract][Full Text] [Related]
12. Transfection of antisense oligodeoxynucleotide inhibits heparanase gene expression and invasive ability of human pancreatic cancer cell in vitro.
Gao J; Su L; Qin R; Chang Q; Huang T; Feng Y
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(1):72-4. PubMed ID: 16711012
[TBL] [Abstract][Full Text] [Related]
13. Heparanase antisense suppression of A-549 lung carcinoma invasion.
Peng C; Ren P; Zhou Q; Sun Q; Zhao X; Cong B
Asian Pac J Cancer Prev; 2011; 12(12):3371-4. PubMed ID: 22471483
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; Nicolson GL
Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
[TBL] [Abstract][Full Text] [Related]
15. Heparanase expression and function during early pregnancy in mice.
D'Souza SS; Daikoku T; Farach-Carson MC; Carson DD
Biol Reprod; 2007 Sep; 77(3):433-41. PubMed ID: 17507691
[TBL] [Abstract][Full Text] [Related]
16. Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?
Hoß SG; Grundmann M; Benkel T; Gockel L; Schwarz S; Kostenis E; Schlesinger M; Ilan N; Vlodavsky I; Bendas G
Thromb Haemost; 2018 Oct; 118(10):1803-1814. PubMed ID: 30235481
[TBL] [Abstract][Full Text] [Related]
17. Nuclear heparanase-1 activity suppresses melanoma progression via its DNA-binding affinity.
Yang Y; Gorzelanny C; Bauer AT; Halter N; Komljenovic D; Bäuerle T; Borsig L; Roblek M; Schneider SW
Oncogene; 2015 Nov; 34(47):5832-42. PubMed ID: 25745999
[TBL] [Abstract][Full Text] [Related]
18. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
19. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based heparanase inhibitors reduce cancer metastasis in vivo.
de Boer C; Armstrong Z; Lit VAJ; Barash U; Ruijgrok G; Boyango I; Weitzenberg MM; Schröder SP; Sarris AJC; Meeuwenoord NJ; Bule P; Kayal Y; Ilan N; Codée JDC; Vlodavsky I; Overkleeft HS; Davies GJ; Wu L
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2203167119. PubMed ID: 35881786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]